There is an established, global pipeline of existing and upcoming monoclonal antibody (MAb) drugs that treat a wide variety of clinical indications. In MAb manufacturing, protein A chromatography is a proven downstream purification process, but there remains a need to reduce total costs while improving purity and yield. The Avantor J.T.Baker BAKERBOND PROchievA recombinant protein A chromatography resin advances the production of MAbs by providing different choices to biopharmaceutical supply chains. Offered both as a bulk resin and as prepackaged laboratory columns, the BAKERBONDÂ® PROchievA resin is suitable for purifying MAbs, FC fusion proteins, and bispecific antibodies. The high-performance resin enables efficiency in workflow processes and protocols.
Fill out the form below to read the complete technology review now.